Latest Earnings Results: Q3 '26
Estimated EPS
-$0.49
Reported EPS
-$0.34
Surprise
+30.72%
Estimated Rev
$15.44M
Reported Rev
$16.19M
Surprise
+4.9%
• Reported GAAP EPS of -$0.34 up 46.88% YoY • Reported revenue of $16.19M up 37.67% YoY • Shoulder Innovations raised full year 2026 net revenue guidance to $68M to $70M, representing growth of approximately 44% to 48% over full year 2025 net revenue.
Bullish Takeaway
Shoulder Innovations grew revenue and implant-system sales with new surgeons and higher existing-customer utilization, reported gross margin of 78.5% versus 76.2%, advanced InSet Go and N-22, and partnered with ALM Ortho.
Bearish Takeaway
Shoulder Innovations reported an unchanged $7.6M operating loss, increased commercial and product-development expenses, and cited dependence on hospital, surgery-center, surgeon and patient adoption among risks to actual results.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.45 | -- | -- | N/A |
Q3 '26 | -$0.49 | -$0.34 | 30.72% | BEAT |
Q2 '26 | -$0.46 | -$0.49 | -6.87% | MISSED |
Q1 '26 | -$0.41 | -$0.41 | -0.10% | MISSED |
Q4 '25 | -$0.39 | -$0.38 | 1.40% | BEAT |